Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDXP | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
mRNA | ZNF669 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | WEE2 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | FAM83F | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | ZNF43 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | NAP1L3 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | C16orf95 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | EMC6 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | LYAR | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |